Stephan Harbarth

37.5k citations

342 papers · 19.3k indexed · 9 hit papers · h-index 68

Impact in

Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 95
- Antibiotic Use and Resistance 95
Molecular Medicine 61
- Antibiotic Resistance in Bacteria 61

Co-authors: Didier Pittet Yehuda Carmeli Stéphane Hugonnet Thomas Perneger Valérie Sauvan Sylvie Touveneau Philippe Mourouga Andie S. Lee
Journals: Clinical Microbiology and Infection (33 papers)Antimicrobial Resistance and Infection Control (32 papers)Infection Control and Hospital Epidemiology (25 papers)Clinical Infectious Diseases (18 papers)Journal of Hospital Infection (18 papers)
Partner nations: Switzerland United States France

In The Last Decade

Stephan Harbarth

330 papers receiving 18.5k citations

Hit Papers

9 papers align trajectories log scale

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. 2022 · 167 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Oxford University Research Archive (ORA) (University of Oxford)
2022 Intensive and Critical Care Nursing
2021 Antimicrobial Resistance and Infection Control
2018 Nature Reviews Disease Primers
2010 Eurosurveillance
2006 American Journal of Respiratory and Critical Care Medicine
2005 Infection Control and Hospital Epidemiology
2001 American Journal of Respiratory and Critical Care Medicine
2000 The Lancet

Peers

Countries citing papers authored by Stephan Harbarth

Since Specialization

Citations

This map shows the geographic impact of Stephan Harbarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Harbarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Harbarth more than expected).

Fields of papers citing papers by Stephan Harbarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Harbarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Harbarth. The network helps show where Stephan Harbarth may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephan Harbarth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephan Harbarth Line = papers co-authored together Stephan Harbarth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sustained effect of a multifaceted VAP prevention program over more than seven years including the COVID-19 pandemic Antimicrobial Resistance and Infection Control ·Andrea Büchler, Harold Kwalwasser, Niccolò Buetti, Filippo Boroli, Olga Gaykova, سمير أوسعيد, Yohei Fukazawa, Caroline Landelle, Stephan Harbarth, Jérôme Pugin	2025	0
2	Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas Journal of Antimicrobial Chemotherapy ·Roberto Sierra, Mélanie Roch, Julien Prados, Aude Nguyen, Abdessalam Cherkaoui, 박병율, Jacques Schrenzel, Stephan Harbarth, Nicolas Vuilleumier, Diego O. Andrey	2025	1
3	Increase in PVC-BSI during the second COVID-19 pandemic year: analysis of catheter and patient characteristics Antimicrobial Resistance and Infection Control ·Manuel M. Ajo, Marie-Céline Zanella, Marcus Vinicius Martins de Menezes, Aude Nguyen, E Martínez Salgado, Marie‐Noëlle Chraïti, Stephan Harbarth, Gaud Catho, 昭美藤原, Niccolò Buetti	2024	1
4	Surgical Antimicrobial Prophylaxis in Low-risk Cholecystectomies is Associated With Fewer Surgical Site Infections Annals of Surgery ·Sofia Cuoco, Andreas F. Widmer, Nicolas Troillet, Guido Beldi, Markus von Flüe, Stephan Harbarth, Rami Sommerstein, (unknown)	2024	1
5	Risk of catheter-associated bloodstream infection by catheter type in a neonatal intensive care unit: a large cohort study of more than 1100 intravascular catheters Journal of Hospital Infection ·Gaud Catho, M. Yu. Naumov, Valérie Sauvan, Nicola Gökbuget, Riccardo Pfister, Olivier Baud, Stephan Harbarth, Niccolò Buetti	2023	5
6	Catheter size and risk of short-term peripheral venous catheter-associated bloodstream infections: an observational study Clinical Microbiology and Infection ·Matteo Faltoni, Gaud Catho, Manuel M. Ajo, Tong-Bing Wu, Marie-Céline Zanella, Marie‐Noëlle Chraïti, E Martínez Salgado, Stephan Harbarth, Niccolò Buetti	2023	2
7	Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland Emerging infectious diseases ·Marie-Céline Zanella, Manuel M. Ajo, Gaud Catho, Marcus Vinicius Martins de Menezes, Marlieke E.A. de Kraker, Aude Nguyen, Marie‐Noëlle Chraïti, Jonathan Sobel, E Martínez Salgado, Stephan Harbarth, Mohamed Abbas, Niccolò Buetti	2023	6
8	Quantification of time delay between screening and subsequent initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)–producing Enterobacterales: A post hoc subgroup analysis of the R-GNOSIS WP5 Trial Infection Control and Hospital Epidemiology ·Friederike Maechler, Frank Schwab, Sonja Hansen, Michael Behnke, Marc J. M. Bonten, Rafael Cantón, Cristina Díaz-Agero Pérez, Carolina Fankhauser, Stephan Harbarth, Benedikt Huttner, Axel Kola, Petra Gastmeier	2023	2
9	Occupational and community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study Antimicrobial Resistance and Infection Control ·Anatoly Chistobayev, Romain Martischang, Julien Sauser, Juliana Bonzanini da Silva, 跃辉张, Christophe Graf, Samuel Cordey, Florian Laubscher, Tomás Robalo Nunes, Walter Zingg, Anne Cori, Stephan Harbarth, Mohamed Abbas	2022	4
10	Building Social-Ecological System Resilience to Tackle Antimicrobial Resistance Across the One Health Spectrum: Protocol for a Mixed Methods Study JMIR Research Protocols ·Irene Lambraki, Shannon E. Majowicz, E. Jane Parmley, Didier Wernli, Anaïs Léger, Tíscar Graells, Qing Yang, Stephan Harbarth, Carolee A. Carson, Patrik J. G. Henriksson, Max Troell, Peter Søgaard Jørgensen	2021	13
11	Effect of an E-Learning Module on Personal Protective Equipment Proficiency Among Prehospital Personnel: Web-Based Randomized Controlled Trial Journal of Medical Internet Research ·Laurent Suppan, Mohamed Abbas, Loric Stuby, Behrouz Azimian, Koji Tachibana, جمشید رزم یار, Anne Iten, Stephan Harbarth, シロヤナギ, Mélanie Suppan	2020	37
12	Teaching Adequate Prehospital Use of Personal Protective Equipment During the COVID-19 Pandemic: Development of a Gamified e-Learning Module JMIR Serious Games ·Mélanie Suppan, シロヤナギ, جمشید رزم یار, Loric Stuby, Bayxonov Bahodirdjon Tursunbayevich, Behrouz Azimian, Mohamed Abbas, Anne Iten, Stephan Harbarth, Laurent Suppan	2020	38
13	Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral Action Clinical Infectious Diseases ·Annelie A Monnier, Jeroen Schouten, Gianpiero Tebano, Veronica Zanichelli, Benedikt Huttner, Céline Pulcini, Christine Årdal, Stephan Harbarth, Marlies Hulscher, Inge C. Gyssens	2018	10
14	Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial Obstetrical & Gynecological Survey ·Angela Huttner, Anna Kowalczyk, ‪Adi Turjeman‬‏, Tanya Babich, Caroline Brossier, Noa Eliakim‐Raz, Оксана Сергеевна Руднева, Begoña Martínez de Tejada, Xavier Le Roux, Shachaf Shiber, Ursula Theuretzbacher, Elodie von Dach, Dafna Yahav, Leonard Leibovici, Maciek Godycki-Ćwirko, Johan W. Mouton, Stephan Harbarth	2018	7
15	Antimicrobial resistance: The complex challenge of measurement to inform policy and the public PLoS Medicine ·Didier Wernli, Peter Søgaard Jørgensen, Stephan Harbarth, Scott P. Carroll, Ramanan Laxminarayan, Nicolas Levrat, John‐Arne Røttingen, Didier Pittet	2017	81
16	Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review Antimicrobial Resistance and Infection Control ·Loris Salvatore Musumeci, Stephan Harbarth, Caroline Landelle	2016	58
17	Carbapénémases: implications cliniques et épidémiologiques pour la Suisse Archive ouverte UNIGE (University of Geneva) ·Mohamed Abbas, Abdessalam Cherkaoui, Carolina Fankhauser, Jacques Schrenzel, Stephan Harbarth	2012	1
18	The European approach to antimicrobial resistance: success stories and challenges Archive ouverte UNIGE (University of Geneva) ·Didier Wernli, Thomas Haustein, Stephan Harbarth	2011	1
19	Gutgläubiger Erwerb von GmbH-Geschäftsanteilen nach dem MoMiG-RegE Stephan Harbarth	2008	1
20	Automatic Alerts for Methicillin-Resistant Staphylococcus aureus Surveillance and Control: Role of a Hospital Information System Infection Control and Hospital Epidemiology ·Didier Pittet, Edith Safran, Stephan Harbarth, F Borst, Arsalan Abu-Much, Peter Rohner, Jean-Raoul Scherrer, R Auckenthaler	1996	90

About Stephan Harbarth

Stephan Harbarth is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 342 papers that have together received 19.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (95 papers), Antimicrobial Resistance in Staphylococcus (82 papers), Bacterial Identification and Susceptibility Testing (78 papers), Antibiotic Resistance in Bacteria (61 papers), Nosocomial Infections in ICU (42 papers), Infection Control in Healthcare (31 papers), Urinary Tract Infections Management (29 papers) and Streptococcal Infections and Treatments (28 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (4.1k citations), Molecular Medicine (3.0k citations), Clinical Biochemistry (3.5k citations), Critical Care and Intensive Care Medicine (2.6k citations) and Infectious Diseases (7.3k citations). Stephan Harbarth has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Didier Pittet, Yehuda Carmeli, Stéphane Hugonnet, Thomas Perneger, Valérie Sauvan, Sylvie Touveneau, Philippe Mourouga, Andie S. Lee, Jacques Schrenzel and Hugo Sax. Their work appears in journals such as Clinical Microbiology and Infection, Antimicrobial Resistance and Infection Control, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and Journal of Hospital Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact